Skip to main content
Caplight Logo









Jotbody (HK) Limited

Jotbody (HK) Limited

Private
Hong KongHealthcare & Life Scienceshttps://jotbody.com/

Last Round

Angel

Apr 26, 2022

Total Funding Raised

$143,000

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Jotbody (HK) Limited is a biotechnology company that specializes in the discovery and development of nanobodies and extracellular vesicles for research and therapeutic applications.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Biotech Equipment

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Application

Keywords

nanobodiesnanobody discoverysingle-domain antibodiessdAbscontract research organizationCROextracellular vesiclesEVsexosomesshark antibodiesAI drug discoveryresearch reagentsAI antibody designnanobody engineeringcamelid antibodiesantibody humanizationprotein production

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Jotbody (HK) Limited Comparables

Compare Jotbody (HK) Limited with similar companies based on industry and business-model similarity.

Jotbody (HK) Limited comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
深圳康体生物医药科技有限公司
85%
Taizhou Baiying Biotechnology
78%
Creative Biolabs
78%

Jotbody (HK) Limited Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AngelApr 26, 2022
SeedDec 16, 2021

Jotbody (HK) Limited Investors

Notable investors and investment history

Jotbody (HK) Limited investors
InvestorRounds
EVX VenturesSeed, Angel
PentepebbleSeed
HK Tech 300Seed, Angel

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 20, 2026

    Monthly visitors increased 78% MoM, reaching 3.8K.

  • Apr 17, 2026

    Monthly visitors increased 36% MoM, from 2.4K to 3.3K.

Jotbody (HK) Limited Filings

Explore SEC and related filing metadata, where available.

Jotbody (HK) Limited filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Jotbody (HK) Limited's valuation, stock price, and market status.

Is Jotbody (HK) Limited a public or private company?

Jotbody (HK) Limited is a private company.

What is the current stock price of Jotbody (HK) Limited?

Jotbody (HK) Limited is a private company with no public stock price. No recent secondary market data is available.

How much is Jotbody (HK) Limited worth (valuation)?

Valuation information for Jotbody (HK) Limited is not publicly available.

Can I buy Jotbody (HK) Limited stock?

Jotbody (HK) Limited shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Jotbody (HK) Limited's last funding round?

Funding round information for Jotbody (HK) Limited is not publicly available.

Who are the main investors in Jotbody (HK) Limited?

Investor information for Jotbody (HK) Limited is not publicly disclosed.

Will Jotbody (HK) Limited IPO soon?

No public IPO plans have been announced for Jotbody (HK) Limited.

How can I track Jotbody (HK) Limited secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Jotbody (HK) Limited's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersHong Kong
Employee Range5
Year Founded2020
Last FundingApr 26, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?